Protein Chromatography Load Optimization Patents: Leaders & Trends 2026
Protein Chromatography Load Optimization Patents: Who Leads and Where the Field Is Open
Filings concentrate modestly at the top. the five most active filers account for 14.8% of all 4,236 records, and the ranked ten hold 23.8% — a leadership cluster, not a monopoly. Filings ran from 164 in 2017 to a peak of 174 in 2020, then declined on a confirmed basis from 113 in 2021 to 75 in 2024 — a 34% drop across that three-year window. Figures for 2025 and 2026 are still filling in and should not be read as a continuation of that decline.
- 1REGENERON PHARMACEUTICALS INC4.6%
- 2EMD MILLIPORE CORP3.4%
- 3F HOFFMANN LA ROCHE & CO AG2.6%
- 4GENENTECH INC2.1%
- 5GENZYME CORP2.1%
See the full protein chromatography load optimization analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about this landscape
Who holds the most patents in protein chromatography load optimization?
The dataset’s ranked list of 100 companies shows a leader with 195 records, well ahead of the fifth-ranked filer at 88 and the tenth at 66. The top five combined account for 14.8% of all 4,236 records in scope, and the top ten for 23.8%, meaning that even the most active filer holds a minority share of the field. This points to a moderately concentrated but not dominated landscape, so freedom-to-operate work should look across the full ranked list rather than at one company alone.
Is patent filing in this field growing or shrinking?
On confirmed data, filings fell from 113 in 2021 to 75 in 2024, a 34% decline, after peaking at 174 in 2020. However, patent publication typically lags filing by around 18 months, so the lower counts shown for 2025 and 2026 are incomplete rather than evidence of a further drop. The safest reading is a real pullback from the 2020 peak through 2024, with the very latest years still unresolved.
What technology areas dominate protein chromatography load optimization patents?
Peptide and protein chemistry claims under C07K appear in 73.2% of the 4,236 records, making it the single most common classification in the dataset. Microorganism and genetic-engineering claims (C12N) follow at 45.3%, and separation-process claims (B01D) at 40.9%. Because a single record can carry multiple IPC codes, these percentages add to more than 100%, but the ordering shows that molecule- and production-route claims outweigh apparatus-specific claims in this field.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Protein Chromatography Load Optimization covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.